Abstract: The invention provides the present invention provides a faecal detection sensor for an absorbent article. The sensor includes a faeces-sensitive material that reacts to the presence of a constituent of faecal matter, wherein the sensor exhibits an electrical property that changes following the reaction of the faeces-sensitive material. In embodiments of the invention the faeces sensitive material is a material that reacts due to the presence of a sulfur-containing compound in faecal matter, such as metallic faeces-sensitive materials, or is a material that reacts with a faecal enzyme and/or other constituents of faecal matter, such as organic faeces-sensitive materials.

Abstract: The invention provides the present invention provides a faecal detection sensor for an absorbent article. The sensor includes a faeces-sensitive material that reacts to the presence of a constituent of faecal matter, wherein the sensor exhibits an electrical property that changes following the reaction of the faeces-sensitive material. In embodiments of the invention the faeces sensitive material is a material that reacts due to the presence of a sulfur-containing compound in faecal matter, such as metallic faeces-sensitive materials, or is a material that reacts with a faecal enzyme and/or other constituents of faecal matter, such as organic faeces-sensitive materials.

Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.